Publications

Sort by: Date | Author | Title

Eskildsen, S., Iranzo, A., Stokholm, M., Staer, K., Ostergaard, K., Eroles, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Borghammer, P., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Tolosa, E., Ostergaard, L. & Pavese, N. (2019). Occurrence of brain capillary dysfunction in patients with REM sleep behavior disorder. S786-S787. Abstract from International Congress of Parkinson's Disease and Movement Disorders, Nice, France.

Khan, A. N., Bronstein, A., Bain, P., Pavese, N. & Nandi, D. (2019). Pedunculopontine and Subthalamic Nucleus Stimulation Effect on Saccades in Parkinson Disease. World Neurosurgery, 126, e219-e231. https://doi.org/10.1016/j.wneu.2019.02.014

Ghadery, C., Best, L. A., Pavese, N., Tai, Y. F. & Strafella, A. P. (2019). PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases. Current Neurology and Neuroscience Reports, 19(7), Article 38. https://doi.org/10.1007/s11910-019-0951-x

Durcan, R., Wiblin, L., Lawson, R. A., Khoo, T. K., Yarnall, A. J., Duncan, G. W., Brooks, D. J., Pavese, N., Burn, D. J. & ICICLE-PD Study Group (2019). Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease. European Journal of Neurology, 26(7), 979-985. https://doi.org/10.1111/ene.13919

Stuart, S., Lawson, R. A., Yarnall, A. J., Nell, J., Alcock, L., Duncan, G. W., Khoo, T. K., Barker, R. A., Rochester, L., Burn, D. J. & ICICLE-PD Study Grp (2019). Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD. Movement Disorders, 34(11), 1690-1698. https://doi.org/10.1002/mds.27813

Tilley, B. S., Smith, C., Pavese, N. & Attems, J. (2019). Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration. BMJ Case Reports, 12(3), Article e228305. https://doi.org/10.1136/bcr-2018-228305

Wang, Y. M., Cai, X. L., Zhang, R. T., Wang, Y., Madsen, K. H., Sørensen, T. A., Møller, A., Cheung, E. F. C. & Chan, R. C. K. (2019). Searchlight classification based on Amplitude of Low Frequency Fluctuation and functional connectivity in individuals with obsessive-compulsive symptoms. Cognitive Neuropsychiatry, 24(5), 322-334. https://doi.org/10.1080/13546805.2019.1658575

Winterdahl, M., Noer, O., Orlowski, D., Schacht, A. C., Jakobsen, S., Alstrup, A. K. O., Gjedde, A. & Landau, A. (2019). Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain. Scientific Reports, 9(1), Article 16918. https://doi.org/10.1038/s41598-019-53430-9

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Edginton, T., Hinz, R., Win, Z., Brooks, D. J. & Edison, P. (2019). Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer's Disease Subjects. Journal of Alzheimer's Disease, 70(2), 455-465. https://doi.org/10.3233/JAD-181168

Jabbari, E., Woodside, J., Tan, M. M. X., Pavese, N., Bandmann, O., Ghosh, B. C. P., Massey, L. A., Capps, E., Warner, T. T., Lees, A. J., Revesz, T., Holton, J. L., Williams, N. M., Grosset, D. G. & Morris, H. R. (2019). The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. Movement Disorders, 34(9), 1307-1314. https://doi.org/10.1002/mds.27786

Glud, A. N., Jakobsen, S., Landau, A., Alstrup, A. K. O. & Sorensen, J. C. (2019). Visualization of intrathecal delivery by PET-imaging. Journal of Neuroscience Methods, 317, 45-48. https://doi.org/10.1016/j.jneumeth.2019.02.003

Kuebler, D., Waechter, T., Cabanel, N., Su, Z., Turkheimer, F. E., Dodel, R., Brooks, D. J., Oertel, W. H. & Gerhard, A. (2019). Widespread microglial activation in multiple system atrophy. Movement Disorders, 34(4), 564-568. https://doi.org/10.1002/mds.27620

Bertelsen, F., Landau, A. M., Vase, K. H., Jacobsen, J., Scheel-Krüger, J. & Møller, A. (2018). Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [C-11]Ro15-4513 microPET study. Brain Research, 1680, 110-114. https://doi.org/10.1016/j.brainres.2017.12.018

Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W.-P., Chen, T., Moeller, A., Brini, M., Fu, Y., Halliday, G., Brudek, T., Aznar, S., Pakkenberg, B., Andersen, J. P. & Jensen, P. H. (2018). Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Reports, 19(5), Article e44617. https://doi.org/10.15252/embr.201744617

Wang, Y.-M., Zou, L.-Q., Xie, W.-L., Yang, Z.-Y., Zhu, X.-Z., Cheung, E. F. C., Sørensen, T. A., Møller, A. & Chan, R. C. K. (2018). Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity. Psychiatry Research, 276, 65-72. https://doi.org/10.1016/j.pscychresns.2018.03.009

Lim, N. K.-H., Moestrup, V. T. S., Zhang, X., Wang, W.-A., Møller, A. & Huang, F.-D. (2018). An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice. Journal of Visualized Experiments, 133(133), Article e56774. https://doi.org/10.3791/56774

Woitalla, D., Dunac, A., Safavi, A., Ceravolo, M. G., Gomez Esteban, J. C., Pavese, N., Asgharnejad, M., Joeres, L., Schuller, J. C. & Chaudhuri, K. R. (2018). A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease. Expert Opinion on Pharmacotherapy, 19(9), 937-945. https://doi.org/10.1080/14656566.2018.1480721

Jansen, W. J., Ossenkoppele, R., Tijms, B. M., Fagan, A. M., Hansson, O., Klunk, W. E., van der Flier, W. M., Villemagne, V. L., Frisoni, G. B., Fleisher, A. S., Lleó, A., Mintun, M. A., Wallin, A., Engelborghs, S., Na, D. L., Chételat, G., Molinuevo, J. L., Landau, S. M., Mattsson, N. ... Amyloid Biomarker Study Group (2018). Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. J A M A Psychiatry, 75(1), 84-95. https://doi.org/10.1001/jamapsychiatry.2017.3391

Jeppesen, J., Otto, M., Frederiksen, Y., Hansen, A. K., Fedorova, T. D., Knudsen, K., Nahimi, A., Brooks, D. J., Borghammer, P. & Sommerauer, M. B. (2018). Automated chin EMG analysis for quantification of REM sleep without atonia. Clinical Neurophysiology, 129(Supplement 1), e76. Article F26. https://doi.org/10.1016/j.clinph.2018.04.189

Sommerauer, M., Hansen, A. K., Parbo, P., Fedorova, T. D., Knudsen, K., Frederiksen, Y., Nahimi, A., Barbe, M. T., Brooks, D. J. & Borghammer, P. (2018). Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients. Movement Disorders, 33(6), 1006-1010. https://doi.org/10.1002/mds.27411

Parbo, P., Ismail, R., Sommerauer, M., Stokholm, M. G., Hansen, A. K., Hansen, K. V., Amidi, A., Schaldemose, J. L., Gottrup, H., Brændgaard, H., Eskildsen, S. F., Borghammer, P., Hinz, R., Aanerud, J. & Brooks, D. J. (2018). Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study. Neurobiology of Disease, 117, 211-216. https://doi.org/10.1016/j.nbd.2018.06.004

Gejl, M., Gjedde, A., Brock, B., Møller, A., van Duinkerken, E., Haahr, H. L., Hansen, C. T., Chu, P.-L., Stender-Petersen, K. L. & Rungby, J. (2018). Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial. Diabetologia, 61(3), 551-561. https://doi.org/10.1007/s00125-017-4502-1

Landau, A. M., Alstrup, A. K. O., Audrain, H., Jakobsen, S., Simonsen, M., Møller, A., Videbech, P. B., Wegener, G., Gjedde, A. & Doudet, D. J. (2018). Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy. Journal of Cerebral Blood Flow and Metabolism, 38(5), 881-887. https://doi.org/10.1177/0271678X17705260

Sommerauer, M., Fedorova, T. D., Hansen, A. K., Knudsen, K., Otto, M., Jeppesen, J., Frederiksen, Y., Blicher, J. U., Geday, J., Nahimi, A., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2018). Evaluation of the noradrenergic system in Parkinson's disease; an 11C-MeNER PET and neuromelanin MRI study. Brain, 141(2), 496-504. https://doi.org/10.1093/brain/awx348

Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Parbo, P., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E. & Pavese, N. (2018). Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder. Neurobiology of Disease, 115, 9-16. https://doi.org/10.1016/j.nbd.2018.02.017

Strafella, A. P., Bohnen, N. I., Pavese, N., Vaillancourt, D. E., van Eimeren, T., Politis, M., Tessitore, A., Ghadery, C., Lewis, S. & IPMDS‐Neuroimaging Study Group (2018). Imaging Markers of Progression in Parkinson's Disease. Movement Disorders Clinical Practice, 5(6), 586-596. https://doi.org/10.1002/mdc3.12673

Lillethorup, T. P., Glud, A. N., Landeck, N., Alstrup, A. K. O., Jakobsen, S., Vang, K., Doudet, D. J., Brooks, D. J., Kirik, D., Hinz, R., Sorensen, J. C. & Landau, A. M. (2018). In vivo quantification of glial activation in minipigs overexpressing human alpha-synuclein. Synapse, 72(12), Article 22060. https://doi.org/10.1002/syn.22060

Knudsen, K., Fedorova, T. D., Hansen, A. K., Sommerauer, M., Otto, M., Svendsen, K. B., Nahimi, A., Stokholm, M. G., Pavese, N., Beier, C. P., Brooks, D. J. & Borghammer, P. (2018). In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurology, 17(7), 618-628. https://doi.org/10.1016/S1474-4422(18)30162-5

Minett, T., Su, L., Mak, E., Williams, G., Firbank, M., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K., Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. & O'Brien, J. T. (2018). Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study. Journal of Neurology, 265(7), 1528-1539. https://doi.org/10.1007/s00415-018-8873-0

Lillethorup, T. P., GLUD, AN., Alstrup, A. K. O., Noer, O., Nielsen, E. H. T., Schacht, A. C., Landeck, N., Kirik, D., Orlowski, D., Sørensen, J. C. H., Doudet, D. J. & Landau, A. (2018). Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs. Scientific Reports, 8(1), Article 15715. https://doi.org/10.1038/s41598-018-34084-5

Hansen, A. K., Brooks, D. J. & Borghammer, P. (2018). MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([(18)F]-AV-1451) Binding. Molecular Imaging and Biology, 20(3), 356-360. https://doi.org/10.1007/s11307-017-1143-1

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T., Brooks, D. J. & Edison, P. (2018). Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Brain, 141(9), 2740-2754. https://doi.org/10.1093/brain/awy188

Chaudhuri, K. R., Poewe, W. & Brooks, D. (2018). Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features. Movement Disorders, 33(6), 909-919. https://doi.org/10.1002/mds.27386

Zou, L.-Q., Zhou, H.-Y., Zhuang, Y., van Hartevelt, T. J., Lui, S. S. Y., Cheung, E. F. C., Møller, A., Kringelbach, M. L. & Chan, R. C. K. (2018). Neural responses during the anticipation and receipt of olfactory reward and punishment in human. Neuropsychologia, 111, 172-179. https://doi.org/10.1016/j.neuropsychologia.2018.02.003

Pavese, N. & Tai, Y. F. (2018). Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism. Movement Disorders Clinical Practice, 5(2), 131-140. https://doi.org/10.1002/mdc3.12590

Lillethorup, T. P., Glud, A. N., Alstrup, A. K. O., Mikkelsen, T. W., Nielsen, E. H. T., Zaer, H., Doudet, D. J., Brooks, D. J., Sørensen, J. C. H., Orlowski, D. & Landau, A. M. (2018). Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs. Experimental Neurology, 303, 142-152. https://doi.org/10.1016/j.expneurol.2018.02.005

Jeppesen, J., Otto, M., Frederiksen, Y., Hansen, A. K., Fedorova, T. D., Knudsen, K., Nahimi, A., Brooks, D. J., Borghammer, P. & Sommerauer, M. (2018). Observations on muscle activity in REM sleep behavior disorder assessed with a semi-automated scoring algorithm. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 129(3), 541-547. https://doi.org/10.1016/j.clinph.2017.12.029

Maxan, A., Mason, S., Saint-Pierre, M., Smith, E., Ho, A., Harrower, T., Watts, C., Tai, Y., Pavese, N., Savage, J. C., Tremblay, M.-È., Gould, P., Rosser, A. E., Dunnett, S. B., Piccini, P., Barker, R. A. & Cicchetti, F. (2018). Outcome of cell suspension allografts in a patient with Huntington's disease. Annals of Neurology, 84(6), 950-956. https://doi.org/10.1002/ana.25354

Lee, J. Y., Lao-Kaim, N. P., Pasquini, J., Deuschl, G., Pavese, N. & Piccini, P. (2018). Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis. Parkinsonism and Related Disorders, 51, 101-104. https://doi.org/10.1016/j.parkreldis.2018.02.039

Fan, Z., Dani, M., Femminella, G. D., Wood, M., Calsolaro, V., Veronese, M., Turkheimer, F., Gentleman, S., Brooks, D. J., Hinz, R. & Edison, P. (2018). Parametric mapping using spectral analysis for C-11-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects. European Journal of Nuclear Medicine and Molecular Imaging, 45(8), 1432-1441. https://doi.org/10.1007/s00259-018-3984-5

Thevathasan, W., Debu, B., Aziz, T., Bloem, B. R., Blahak, C., Butson, C., Czernecki, V., Foltynie, T., Fraix, V., Grabli, D., Joint, C., Lozano, A. M., Okun, M. S., Ostrem, J., Pavese, N., Schrader, C., Tai, C.-H., Krauss, J. K., Moro, E. & Movement Disorders Society PPN DBS Working Groupin collaboration with the World Society for Stereotactic and Functional Neurosurgery (2018). Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review. Movement Disorders, 33(1), 10-20. https://doi.org/10.1002/mds.27098

Xu, Z., Arbizu, J. & Pavese, N. (2018). PET Molecular Imaging in Atypical Parkinsonism. International Review of Neurobiology, 142, 3-36. https://doi.org/10.1016/bs.irn.2018.09.001

Alstrup, A. K. O., Munk, O. L., Landau, A. M. & Lillethorup, T. P. (2018). PET radioligand injection for pig neuroimaging. Scandinavian Journal of Laboratory Animal Science, 44(2), 1-5.

Mattsson, N., Groot, C., Jansen, W. J., Landau, S. M., Villemagne, V. L., Engelborghs, S., Mintun, M. M., Lleo, A., Molinuevo, J. L., Jagust, W. J., Frisoni, G. B., Ivanoiu, A., Chételat, G., Resende de Oliveira, C., Rodrigue, K. M., Kornhuber, J., Wallin, A., Klimkowicz-Mrowiec, A., Kandimalla, R. ... Ossenkoppele, R. (2018). Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia, 14(7), 913-924. https://doi.org/10.1016/j.jalz.2018.02.009

Xu, Z., Anderson, K., Lawson, R., Brooks, D. J. & Pavese, N. (2018). Progression of sleep disorders spectrum in Parkinson's Disease: A 5 year clinical longitudinal study. Movement Disorders, 33, S761-S762.

Pasquini, J., Ceravolo, R., Qamhawi, Z., Lee, J.-Y., Deuschl, G., Brooks, D. J., Bonuccelli, U. & Pavese, N. (2018). Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study. Brain, 141(3), 811-821. https://doi.org/10.1093/brain/awx376

Edison, P. & Brooks, D. J. (2018). Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET. Journal of Alzheimer's Disease, 64(s1), S339-S351. https://doi.org/10.3233/JAD-179929

McGinnity, C. J., Barros, D. A. R., Trigg, W., Brooks, D. J., Hinz, R., Duncan, J. S., Koepp, M. J. & Hammers, A. (2018). Simplifying [ ¹⁸F]GE-179 PET: are both arterial blood sampling and 90-min acquisitions essential? EJNMMI research, 8, Article 46. https://doi.org/10.1186/s13550-018-0396-2

Ismail, R., Hansen, A. K., Parbo, P., Brændgaard, H., Gottrup, H., Brooks, D. J. & Borghammer, P. (2018). The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease. International Journal of Alzheimer's Disease, 2018, 6852303. Article 6852303. https://doi.org/10.1155/2018/6852303

Martis, L.-S., Tran, T. P., Bouzinova, E., Christiansen, S. L., Møller, A., Holmes, M. C. & Wiborg, O. (2018). The effect of rat strain and stress exposure on performance in touchscreen tasks. Physiology & Behavior, 184, 83-90. https://doi.org/10.1016/j.physbeh.2017.11.010

Helmich, R. C., Vaillancourt, D. E. & Brooks, D. J. (2018). The future of brain imaging in Parkinson's disease. Journal of Parkinson's Disease, 8(s1), S47-S51. https://doi.org/10.3233/JPD-181482

Pavese, N. & the Parkinson's Progression Markers Initiative (2018). The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort. Annals of clinical and translational neurology, 5(12), 1460-1477. https://doi.org/10.1002/acn3.644

Fan, Z., Brooks, D. J., Okello, A. & Edison, P. (2017). An early and late peak in microglial activation in Alzheimer's disease trajectory. Brain, 140(3), 792-803. https://doi.org/10.1093/brain/aww349

Yousif, N., Mace, M., Pavese, N., Borisyuk, R., Nandi, D. & Bain, P. (2017). A Network Model of Local Field Potential Activity in Essential Tremor and the Impact of Deep Brain Stimulation. PLOS Computational Biology, 13(1), e1005326. Article e1005326. https://doi.org/10.1371/journal.pcbi.1005326

Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E. & Pavese, N. (2017). Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurology, 16(10), 789-796. https://doi.org/10.1016/S1474-4422(17)30173-4

Angeles, P., Tai, Y., Pavese, N., Wilson, S. & Vaidyanathan, R. (2017). Automated assessment of symptom severity changes during deep brain stimulation (DBS) therapy for Parkinson's disease. In 2017 International Conference on Rehabilitation Robotics, ICORR 2017 (Vol. 2017, pp. 1512-1517). Article 8009462 https://doi.org/10.1109/ICORR.2017.8009462

Arshad, Q., Bonsu, A., Lobo, R., Fluri, A.-S., Sheriff, R., Bain, P., Pavese, N. & Bronstein, A. M. (2017). Biased numerical cognition impairs economic decision-making in Parkinson's disease. Annals of clinical and translational neurology, 4(10), 739-748. https://doi.org/10.1002/acn3.449

Fjældstad, A., Fernandes, H., van Hartevelt, T. J., Gleesborg, C., Møller, A., Ovesen, T. & Kringelbach, M. L. (2017). Brain fingerprints of olfaction: a novel structural method for assessing olfactory cortical networks in health and disease. Scientific Reports, 7(7), Article 42534. https://doi.org/10.1038/srep42534

Parbo, P., Ismail, R., Hansen, K. V., Amidi, A., Mårup, F. H., Gottrup, H., Brændgaard, H., Eriksson, B. O. M., Eskildsen, S. F., Lund, T. E., Tietze, A., Edison, P., Pavese, N., Stokholm, M. G., Borghammer, P., Hinz, R., Aanerud, J. & Brooks, D. J. (2017). Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease. Brain, 140(7), 2002-2011. https://doi.org/10.1093/brain/awx120

Nielsen, R. B., Egefjord, L., Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H., Rungby, J., Eskildsen, S. F. & Østergaard, L. (2017). Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease. Alzheimer's & Dementia, 13(10), 1143-1153. https://doi.org/10.1016/j.jalz.2017.02.007

Firbank, M. J., Yarnall, A. J., Lawson, R. A., Duncan, G. W., Khoo, T. K., Petrides, G. S., O'Brien, J. T., Barker, R. A., Maxwell, R. J., Brooks, D. J. & Burn, D. J. (2017). Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study. Journal of Neurology, Neurosurgery & Psychiatry, 88(4), 310-316. https://doi.org/10.1136/jnnp-2016-313918

Politis, M., Wilson, H., Wu, K., Brooks, D. J. & Piccini, P. (2017). Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients. NeuroImage: Clinical, 16, 455-460. https://doi.org/10.1016/j.nicl.2017.08.013

Fedorova, T. D., Seidelin, L. B., Knudsen, K., Schacht, A. C., Geday, J., Pavese, N., Brooks, D. J. & Borghammer, P. (2017). Decreased intestinal acetylcholinesterase in early Parkinson disease; An 11C-donepezil PET study. Neurology, 88(8), 775-781. https://doi.org/10.1212/WNL.0000000000003633

Phan, J.-A., Stokholm, K., Zareba-Paslawska, J., Jakobsen, S., Vang, K., Gjedde, A., Landau, A. M. & Romero-Ramos, M. (2017). Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease. Scientific Reports, 7(1), Article 6363. https://doi.org/10.1038/s41598-017-06724-9

Pilegaard, A. M., Berendt, M., Holst, P., Møller, A. & McEvoy, F. J. (2017). Effect of Skull Type on the Relative Size of Cerebral Cortex and Lateral Ventricles in Dogs. Frontiers in Veterinary Science, 4(MAR), 30. Article 30. https://doi.org/10.3389/fvets.2017.00030

Borghammer, P., Knudsen, K., Fedorova, T. D. & Brooks, D. J. (2017). Imaging Parkinson's disease below the neck. npj Parkinson's Disease , 3(1), 15. Article 0017. https://doi.org/10.1038/s41531-017-0017-1

Bertelsen, F., Møller, A., Folloni, D., Drasbek, K. R., Scheel-Krüger, J. & Landau, A. M. (2017). Increased GABA_A receptor binding in amygdala after prenatal administration of valproic acid to rats. Acta Neuropsychiatrica, 29(5), 309-3014. https://doi.org/10.1017/neu.2016.59

Gredal, H., Thomsen, B. B., Boza-Serrano, A., Garosi, L., Rusbridge, C., Anthony, D., Møller, A., Finsen, B., Deierborg, T., Lambertsen, K. L. & Berendt, M. (2017). Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke. NeuroReport, 28(3), 134-140. https://doi.org/10.1097/WNR.0000000000000728

Peraza, L. R., Nesbitt, D. J., Lawson, R. A., Duncan, G. W., Yarnall, A. J., Khoo, T. K., Kaiser, M., Firbank, M. J., O'Brien, J. T., Barker, R. A., Brooks, D. J., Burn, D. J. & Taylor, J.-P. (2017). Intra-and Inter-Network Functional Alterations in Parkinson's Disease with Mild Cognitive Impairment. Human Brain Mapping, 38(3), 1702-1715. https://doi.org/10.1002/hbm.23499

Hansen, A. K., Damholdt, M. F., Fedorova, T. D., Knudsen, K., Parbo, P., Ismail, R., Østergaard, K., Brooks, D. J. & Borghammer, P. (2017). In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography. Movement Disorders, 32(6), 922-927. https://doi.org/10.1002/mds.26961

Sommerauer, M. B., Hansen, A., Fedorova, T., Knudsen, K., Frederiksen, Y., Damholdt, M. F., Jeppesen, J., Otto, M., Nahimi, A., Brooks, D. & Borghammer, P. (2017). LBA 39 Noradrenergic deficit in Parkinson’s disease patients with REM sleep behavior disorder is linked to cognitive performance – A 11C - MeN ER PET & neuromelanin MRI study. Abstract from 2017 International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, British Columbia, Canada. http://www.mdscongress2017.org/Congress-2017-Files/PDF/LBASGGPT.pdf

Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Mollenhauer, B., Owen, A. M., Khoo, T. K., Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2017). Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease. Neurobiology of Aging, 55, 78-90. https://doi.org/10.1016/j.neurobiolaging.2017.03.012

Strafella, A. P., Bohnen, N. I., Perlmutter, J. S., Eidelberg, D., Pavese, N., Van Eimeren, T., Piccini, P., Politis, M., Thobois, S., Ceravolo, R., Higuchi, M., Kaasinen, V., Masellis, M., Peralta, M. C., Obeso, I., Pineda-Pardo, J. Á., Cilia, R., Ballanger, B., Niethammer, M. ... IPMDS-Neuroimaging Study Group (2017). Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Movement Disorders, 32(2), 181-192. https://doi.org/10.1002/mds.26907

Lillethorup, T. P., Glud, A. N., Jakobsen, S., Alstrup, A. K. O., Moeller, A., Sørensen, J. C. H., Doudet, D. J. & Landau, A. M. (2017). Multi-Neurotransmitter Deficits in a Minipig Model of Parkinson´s Disease. Poster session presented at Psykiatriens 12. forskningsdag, Aarhus, Denmark.

Lillethorup, T. P., GLUD, AN., Jakobsen, S., Alstrup, A. K. O., Moeller, A., Sørensen, J. C. H., Doudet, D. J. & Landau, A. M. (2017). Multi-Neurotransmitter Deficits in a Minipig Model of Parkinson’s Disease. Poster session presented at 1st Annual Research Meeting, Aarhus, Denmark.

Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., Lehericy, S., Brooks, D. J., Rothwell, J. C., Hallett, M., DeLong, M. R., Marras, C., Tanner, C. M., Ross, G. W., Langston, J. W. ... Stoessl, A. J. (2017). Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement Disorders, 32(9), 1264-1310. https://doi.org/10.1002/mds.27115

Landau, A. M., Wegener, G., Jakobsen, S., Orlowski, D., Thomsen, M., Schacht, A. C., Alstrup, A. K. O., Jacobsen, J., Mørk, A., Sørensen, J. C. H. & Doudet, D. J. (2017). PET-microdialysis study of noradrenaline release in pig brain. Poster session presented at Psykiatriens 12. forskningsdag, Aarhus, Denmark.

Phan, J.-A., Landau, A. M., Jakobsen, S. & Gjedde, A. (2017). Radioligand binding analysis of α 2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding. Scientific Reports, 7(7), Article 15979. https://doi.org/10.1038/s41598-017-16020-1

Elmholdt, E.-M., Skewes, J. C., Dietz, M., Møller, A., Jensen, M. S., Roepstorff, A., Wiech, K. & Staehelin-Jensen, T. (2017). Reduced Pain Sensation and Reduced BOLD Signal in Parietofrontal Networks during Religious Prayer. Frontiers in Human Neuroscience, 11, Article 337. https://doi.org/10.3389/fnhum.2017.00337

ICICLE-PD Study Group (2017). Stability of mild cognitive impairment in newly diagnosed Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 88(8), 648-652. https://doi.org/10.1136/jnnp-2016-315099

Bertelsen, F., Folloni, D., Møller, A., Landau, A. M., Scheel-Krüger, J. & Winterdahl, M. (2017). Suppressed play behaviour and decreased oxytocin receptor binding in the amygdala after prenatal exposure to low-dose valproic acid. Behavioural Pharmacology, 28(6), 450-457. https://doi.org/10.1097/FBP.0000000000000316

Dani, M., Brooks, D. J. & Edison, P. (2017). Suspected non-Alzheimer's pathology - Is it non-Alzheimer's or non-amyloid? Ageing Research Reviews, 36, 20-31. https://doi.org/10.1016/j.arr.2017.02.003

Politis, M., Sauerbier, A., Loane, C., Pavese, N., Martin, A., Corcoran, B., Brooks, D. J., Ray Chaudhuri, K. & Piccini, P. (2017). Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients. Movement Disorders, 32(2), 235-240. https://doi.org/10.1002/mds.26848

Winterdahl, M., Noer, O., Orlowski, D., Jakobsen, S., Alstrup, A. K. O., Scheel-Krüger, J., Kringelbach, M. L., Møller, A. & Landau, A. M. (2017). The “addicted” minipig brain: Sugar intake decreases dopamine D2/3 receptor availability in brain regions implicated in addiction. Poster session presented at 1st Annual Research Meeting, Aarhus, Denmark.

Buckley, C. J., Sherwin, P. F., Smith, A. P. L., Wolber, J., Weick, S. M. & Brooks, D. J. (2017). Validation of an electronic image reader training programme for interpretation of [F-18]flutemetamol beta- amyloid PET brain images. Nuclear Medicine Communications, 38(3), 234-241. https://doi.org/10.1097/MNM.0000000000000633

Pagano, G., Ferrara, N., Brooks, D. J. & Pavese, N. (2016). Age at onset and Parkinson disease phenotype. Neurology, 86(15), 1400-1407. https://doi.org/10.1212/WNL.0000000000002461

Scott LeBlanc, G., Ramlackhansingh, A. F., Edison, P., Hellyer, P. J., Cole, J., Veronese, M., Leech, R., Greenwood, R. J., Turkheimer, F. E., Gentleman, S. M., Heckemann, R. A., Matthews, P. M., Brooks, D. J. & Sharp, D. J. (2016). Amyloid pathology and axonal injury after brain trauma. Neurology, 86(9), 821-828. https://doi.org/10.1212/WNL.0000000000002413

Chaudhuri, K. R., Rojo, J. M., Schapira, A. H. V., Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. G. & Martinez-Martin, P. (2016). A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need (vol 8, e57221, 2013). P L o S One, 11(2), Article 0150130. https://doi.org/10.1371/journal.pone.0150130

Fredsø, N., Sabers, A., Toft, N., Møller, A. & Berendt, M. (2016). A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy. Veterinary Journal, 208, 44-9. https://doi.org/10.1016/j.tvjl.2015.10.018

Angeles, P., Mace, M., Admiraal, M., Burdet, E., Pavese, N. & Vaidyanathan, R. (2016). A Wearable Automated System to Quantify Parkinsonian Symptoms Enabling Closed Loop Deep Brain Stimulation. In L. Alboul, D. Damian & JM. Aitken (Eds.), Towards Autonomous Robotic Systems - 17th Annual Conference, TAROS 2016, Proceedings (pp. 8-19). SPRINGER INT PUBLISHING AG. https://doi.org/10.1007/978-3-319-40379-3_2

Khan, J., Quamhawi, Z., Tai, Y. F., Bain, P. G., Nandi, D., Gunning, S. & Pavese, N. (2016). Cognitive change following deep brain stimulation in patients with movement disorders. Movement Disorders, 31, S38-S38.

Nielsen, R. B., Egefjord, L., Eskildsen, S. F., Møller, A., Brændgaard, H., Jensen, M. G., Brock, B., Rungby, J. & Østergaard, L. (2016). Disruption of microvascular flow-patterns in Alzheimer's disease correlates with neurodegeneration and cognitive decline. Abstract from 10th FENS Forum of Neuroscience 2016.

Femminella, G. D., Ninan, S., Atkinson, R., Fan, Z., Brooks, D. J. & Edison, P. (2016). Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia? Journal of Alzheimer's Disease, 51(4), 1275-1289. https://doi.org/10.3233/JAD-150827

Shakweh, E., Pearce, R. B. & Pavese, N. (2016). Effect of botulinum toxin on the non-motor symptoms of dystonia. Movement Disorders, 31, S566-S566.

Lou, H. O. C., Rosenstand, A., Brooks, D. J., Bender, D., Jakobsen, S., Blicher, J. U., Hansen, K. V. & Møller, A. (2016). Exogenous dopamine reduces GABA receptor availability in the human brain. Brain and Behavior, 6(7), e00484. Article e00484. https://doi.org/10.1002/brb3.484

Fan, Z., Calsolaro, V., Atkinson, R. A., Femminella, G. D., Waldman, A., Buckley, C. J., Trigg, W., Brooks, D. J., Hinz, R. & Edison, P. (2016). Flutriciclamide (F-18-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein. Journal of Nuclear Medicine, 57(11), 1753-1759. https://doi.org/10.2967/jnumed.115.169078

Pavese, N. & Tai, Y. F. (2016). Genetic and degenerative disorders primarily causing other movement disorders. In Neuroimaging Part I, 2016 (Vol. 135, pp. 507-23) https://doi.org/10.1016/B978-0-444-53485-9.00025-8

DellaValle, B., Brix, G. S., Brock, B., Jensen, M. G., Landau, A. M., Møller, A., Rungby, J. & Larsen, A. (2016). Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats. Frontiers in Pharmacology, 7(NOV), 433. Article 433. https://doi.org/10.3389/fphar.2016.00433

Duncan, G. W., Firbank, M. J., Yarnall, A. J., Khoo, T. K., Brooks, D. J., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2016). Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Movement Disorders, 31(1), 103-110. https://doi.org/10.1002/mds.26312

Breen, D. P., Nombela, C., Vuono, R., Jones, P. S., Fisher, K., Burn, D. J., Brooks, D. J., Reddy, A. B., Rowe, J. B. & Barker, R. A. (2016). Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease. Movement Disorders, 31(7), 1062-1066. https://doi.org/10.1002/mds.26592

Dani, M., Edison, P. & Brooks, D. J. (2016). Imaging biomarkers in tauopathies. Parkinsonism and Related Disorders, 22, S26-S28. https://doi.org/10.1016/j.parkreldis.2015.08.011

Brooks, D. J. (2016). Imaging of genetic and degenerative disorders primarily causing Parkinsonism. In R. G. Gonzalez & J. C. Masdeu (Eds.), Neuroimaging Part I, 2016 (pp. 493-505). Elsevier B.V. https://doi.org/10.1016/B978-0-444-53485-9.00024-6

Brooks, D. J. & Tambasco, N. (2016). Imaging Synucleinopathies. Movement Disorders, 31(6), 814-829. https://doi.org/10.1002/mds.26547

Borghammer, P., Knudsen, K. & Brooks, D. J. (2016). Imaging Systemic Dysfunction in Parkinson's Disease. Current Neurology and Neuroscience Reports, 16(6), 51. Article 51. https://doi.org/10.1007/s11910-016-0655-4

Hansen, A. K., Knudsen, K., Lillethorup, T. P., Landau, A. M., Parbo, P., Fedorova, T., Audrain, H., Bender, D., Østergaard, K., Brooks, D. J. & Borghammer, P. (2016). In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Brain, 139(7), 2039-2049. https://doi.org/10.1093/brain/aww098

Hansen, A., Knudsen, K., Fedorova, T. D., Parbo, P., Østergaard, K., Brooks, D. & Borghammer, P. (2016). In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Poster session presented at International Congress of Parkinson’s Disease and Movement Disorders, Berlin, Germany.

Feeney, C., Scott LeBlanc, G., Raffel, J., Roberts, S., Coello, C., Jolly, A., Searle, G., Goldstone, A. P., Brooks, D. J., Nicholas, R. S., Trigg, W., Gunn, R. N. & Sharp, D. J. (2016). Kinetic analysis of the translocator protein positron emission tomography ligand [F-18]GE-180 in the human brain. European journal of nuclear medicine and molecular imaging, 43(12), 2201-2210. https://doi.org/10.1007/s00259-016-3444-z

Brooks, D. J. (2016). Molecular imaging of dopamine transporters. Ageing Research Reviews, 30, 114-121. https://doi.org/10.1016/j.arr.2015.12.009

Thomsen, M. B., Lillethorup, T. P., Jakobsen, S., Nielsen, E. H., Simonsen, M., Wegener, G., Landau, A. M. & Tasker, A. (2016). Neonatal domoic acid alters in vivo binding of [(11)C]yohimbine to α2-adrenoceptors in adult rat brain. Psychopharmacology, 233(21), 3779-3785. https://doi.org/10.1007/s00213-016-4416-5

McDonald, C., Lawson, R. A., Duncan, G. W., Khoo, T. K., Brooks, D. J., Barker, R. A., Yarnall, A. J. & Burn, D. J. (2016). Prevalence and risk factors for orthostatic hypotension in early PD. Movement Disorders, 31, S120-S120.

Taylor, S., Gafton, J., Shah, B., Pagano, G., Chaudhuri, K. R., Brooks, D. J. & Pavese, N. (2016). Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism. Movement Disorders, 31(3), 344-51. https://doi.org/10.1002/mds.26456

Glud, A. N., Lillethorup, T. P., Landeck, N., Alstrup, A. K. O., Johnsen, E. L., Brooks, D., Kirik, D., Bjarkam, C., Landau, A. M. & Sørensen, J. C. H. (2016). PROTEIN AGREGATION MODELS OF PARKINSONS DISEASE USING VIRAL VECTORS, PROTEASOME INHIBITION AND INOCULATION OF PREFORMED FIBRILS IN THE GOTTINGEN MINIPIG CNS. Poster session presented at Aarhus University Graduate School of Health, PhD Day 2016: set science free, Denmark.

Pagano, G., Molloy, S., Bain, P. G., Rabiner, E. A., Chaudhuri, K. R., Pavese, N. & Brooks, D. (2016). Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease. Neurology, 87(23), 2451-2456. https://doi.org/10.1212/WNL.0000000000003396

Dani, M., Brooks, D. J. & Edison, P. (2016). Tau imaging in neurodegenerative diseases. European journal of nuclear medicine and molecular imaging, 43(6), 1139-1150. https://doi.org/10.1007/s00259-015-3231-2

Pavese, N., Rodemark, S., Tai, Y. F., Yousif, N., Nandi, D. & Bain, P. G. (2016). Traditional trial-and-error versus neuroanatomical-3D-image software-assisted deep brain stimulation programming in patients with Parkinson's disease. Movement Disorders, 31, S30-S31.

Lingford-Hughes, A. R., Myers, J. F., Watson, B. J., Reid, A. G., Kalk, N. J., Feeney, A., Hammers, A., Riaño Barros, D. A., McGinnity, C. J., Taylor, L. G., Rosso, L., Brooks, D. J., Turkheimer, F. E. & Nutt, D. J. (2016). Using [C-11]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism. NeuroImage, 132, 1-7. https://doi.org/10.1016/j.neuroimage.2016.02.005

Landau, A. M., Dyve, S., Jakobsen, S., Alstrup, A. K. O., Gjedde, A. & Doudet, D. (2015). Acute Vagal Nerve Stimulation Lowers α2 Adrenoceptor Availability: Possible Mechanism of Therapeutic Action. Brain Stimulation, 8(4), 702-707. https://doi.org/10.1016/j.brs.2015.02.003

Senda, M., Yamamoto, Y., Sasaki, M., Yamane, T., Brooks, D. J., Farrar, G., McParland, B. J. & Heurling, K. (2015). An exploratory efficacy study of the amyloid imaging agent [F-18]flutemetamol in Japanese Subjects. Annals of nuclear medicine, 29(5), 391-399. https://doi.org/10.1007/s12149-015-0957-7

Yarnall, A. J., Lawson, R. A., Duncan, G. W., Breen, D. P., Khoo, T. K., Brooks, D., Barker, R. A., Taylor, J. P. & Burn, D. J. (2015). Anticholinergic Load: Is there a cognitive cost in early Parkinson's disease? Journal of Parkinson's Disease, 5(4), 743-747. https://doi.org/10.3233/JPD-150664

Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K., Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2015). Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain, 138(10), 2974-2986. https://doi.org/10.1093/brain/awv211

Lillethorup, T. P., Glud, A. N., Sørensen, J. C. H., Landau, A. M., Jakobsen, S. & Jakobsen, S. (2015). Brain Serotonin Transporter Binding In a Minipig Model of Parkinson's Disease. Poster session presented at Brain & Brain PET 2015, Vancouver, Canada.

Fan, Z., Harold, D., Pasqualetti, G., Williams, J., Brooks, D. J. & Edison, P. (2015). Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort? Journal of Nuclear Medicine, 56(5), 707-713. https://doi.org/10.2967/jnumed.114.149443

Brooks, D. J. (2015). Chorea and Other Hyperkinetic Disorders. In Social Cognitive Neuroscience, Cognitive Neuroscience, Clinical Brain Mapping (Vol. 3, pp. 751-757). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-397025-1.00086-5

Qamhawi, Z., Towey, D., Shah, B., Pagano, G., Seibyl, J., Marek, K., Borghammer, P., Brooks, D. J. & Pavese, N. (2015). Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Brain, 138, 2964-2973. https://doi.org/10.1093/brain/awv215

Weintraub, D., Simuni, T., Caspell-Garcia, C., Coffey, C., Lasch, S., Siderowf, A., Aarsland, D., Barone, P., Burn, D., Chahine, L. M., Eberling, J., Espay, A. J., Foster, E. D., Leverenz, J. B., Litvan, I., Richard, I., Troyer, M. D., Hawkins, K. A., Marek, K. ... Hogarth, P. (2015). Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Movement Disorders, 30(7), 919-927. https://doi.org/10.1002/mds.26170

PPMI Sleep Working group on behalf of the PPMI Investigators (2015). Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. Movement Disorders, 30(10), 1371-1381. https://doi.org/10.1002/mds.26248

Ashraf, A., Fan, Z., Brooks, D. J. & Edison, P. (2015). Cortical hypermetabolism in MCI subjects: a compensatory mechanism? European journal of nuclear medicine and molecular imaging, 42(3), 447-458. https://doi.org/10.1007/s00259-014-2919-z

Landau, A. M., Phan, J.-A., Iversen, P., Lillethorup, T. P., Simonsen, M., Wegener, G., Jakobsen, S. & Doudet, D. J. (2015). Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression. Neuropharmacology, 91, 97-102. https://doi.org/10.1016/j.neuropharm.2014.12.025

Lillethorup, T. P., Iversen, P., Fontain, J., Wegener, G., Doudet, D. J. & Landau, A. M. (2015). Electroconvulsive shocks decrease α2-adrenoceptor binding in the Flinders rat model of depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 404-412. https://doi.org/10.1016/j.euroneuro.2014.12.003

van Hartevelt, T. J., Cabral, J., Møller, A., FitzGerald, J. J., Green, A. L., Aziz, T. Z., Deco, G. & Kringelbach, M. L. (2015). Evidence from a rare case study for Hebbian-like changes in structural connectivity induced by long-term deep brain stimulation. Frontiers in Behavioral Neuroscience, 9, 167. https://doi.org/10.3389/fnbeh.2015.00167

Bannon, D., Landau, A. M. & Doudet, D. J. (2015). How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease? Current Neurology and Neuroscience Reports, 15(8), 571. https://doi.org/10.1007/s11910-015-0571-z

Gjerløff, T., Fedorova, T. D., Knudsen, K., Munk, O. L., Nahimi, A., Jacobsen, S., Danielsen, E. H., Terkelsen, A. J., Hansen, J., Pavese, N., Brooks, D. J. & Borghammer, P. (2015). Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET. Brain, 138(3), 653-663. https://doi.org/10.1093/brain/awu369

Varley, J., Brooks, D. J. & Edison, P. (2015). Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions. Alzheimer's & Dementia, 11(9), 1110-1120. https://doi.org/10.1016/j.jalz.2014.08.105

Alstrup, A. K. O., Landau, A. M., Winterdahl, M., Zeidler, D., Jensen, S. B., Munk, O. L. & Sørensen, J. C. H. (2015). Imaging Techniques with CT, MRI, PET, and SPECT. In Swine in the laboratory CRC Press Inc..

Thomsen, M., Lillethorup, T. P., Wegener, G., Tasker, A. & Landau, A. M. (2015). Increased receptor density of α2 adrenoceptors and GABAA α5 receptors in limbic brain regions in the domoic acid rat model of epilepsy. Abstract from OAK Meeting 2015, Aarhus, Denmark.

Glud, A. N., Landau, A. M., Johnsen, E. L., Bjarkam, C. R., Brooks, D., Kirik, D. & Sørensen, J. C. H. (2015). LARGE ANIMAL PARKINSONS DISEASE MODELS USING VIRAL VECTORS AND INOCULATION OF PREFORMED FIBRILS TO MEDIATE ALPHA-SYNUCLEIN OVEREXPRESSION AND MISFOLDING IN THE GOTTINGEN MINIPIG CNS.

Fan, Z., Okello, A. A., Brooks, D. J. & Edison, P. (2015). Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. Brain, 138(Pt 12), 3685-98. https://doi.org/10.1093/brain/awv288

Thomsen, M., Lillethorup, T. P., Jakobsen, S., Nielsen, E. H. T., Simonsen, M., Wegener, G., Tasker, A. & Landau, A. M. (2015). Neonatal domoic acid decreases in vivo binding of [11C]yohimbine to α2 adrenoceptors in adult rat brain. Poster session presented at Brain & Brain PET 2015, Vancouver, Canada.

Thomsen, M., Lillethorup, T. P., Wegener, G., Tasker, A. & Landau, A. M. (2015). Neonatal domoic acid increases receptor density of α2 adrenoceptors and GABAA α5 receptors in limbic brain regions of adult rats. Poster session presented at 56th Annual Congress of the Scandinavian College of Neuro-Psychopharmacology, Copenhagen, Denmark.

Brooks, D. J. (2015). Neuroimaging in Parkinson's disease: a future perspective. Neurodegenerative Disease Management, 5(2), 105-108. https://doi.org/10.2217/nmt.14.56

Heneka, M. T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G. C. ... Kummer, M. P. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology, 14(4), 388-405.

McGinnity, C. J., Koepp, M. J., Hammers, A., Barros, D. A. R., Pressler, R. M., Luthra, S. K., Jones, M. P. A., Trigg, W., Micallef, C., Symms, M. R., Brooks, D. J. & Duncan, J. S. (2015). NMDA receptor binding in focal epilepsies. Journal of Neurology, Neurosurgery & Psychiatry, 86(10), 1150-1157. https://doi.org/10.1136/jnnp-2014-309897

Fjaeldstad, A., Kjaergaard, T., van Hartevelt, T. J., Moeller, A., Kringelbach, M. L. & Ovesen, T. (2015). Olfactory screening: Validation of Sniffin' Sticks in Denmark. Clinical Otolaryngology, 40(6), 545-550. https://doi.org/10.1111/coa.12405

Glud, A. N., Landau, A. M., Lillethorup, T. P., Landeck, N., Johnsen, E. L., Bjarkam, C. R., Brooks, D., Kirik, D. & Sørensen, J. C. H. (2015). PARKINSON’S DISEASE MODELS OF ABNORMAL PROTEIN AGGREGATION IN THE GOTTINGEN MINIPIG CNS.

Glud, A. N., Landau, A. M., Lillethorup, T. P., Landeck, N., Johnsen, E. L., Alstrup, A. K. O., Bjarkam, C. R., Brooks, D., Kirik, D. & Sørensen, J. C. H. (2015). PARKINSON’S DISEASE MODELS OF ABNORMAL PROTEIN AGGREGATION IN THE GOTTINGEN MINIPIG CNS: Brain Prize Meeting 2015.

Vibholm, A. K., Landau, A. M., Winterdahl, M., Jakobsen, S., Alstrup, A. K. O., Simonsen, M., Bender, D., Møller, A., Pavese, N., Sørensen, J. C. H. & Brooks, D. (2015). Preclinical in-vivo imaging of activated NMDA receptor ion channels with the novel radioligand 18F-GE179. Abstract from Pd.d.-dag, Aarhus, Denmark.

Brooks, D. J. & Amyloid PET Study Group (2015). Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA: The Journal of the American Medical Association, 313(19), 1939-1949. https://doi.org/10.1001/jama.2015.4669

Phan, J.-A., Landau, A. M., Wong, D. F., Jakobsen, S., Nahimi, A., Doudet, D. J. & Gjedde, A. (2015). Quantification of [(11)C]yohimbine binding to α2 adrenoceptors in rat brain in vivo. Journal of Cerebral Blood Flow and Metabolism, 35(3), 501-511. https://doi.org/10.1038/jcbfm.2014.225

Scott, G., Hellyer, P. J., Ramlackhansingh, A. F., Brooks, D. J., Matthews, P. M. & Sharp, D. J. (2015). Thalamic inflammation after brain trauma is associated with thalamo-cortical white matter damage. Journal of Neuroinflammation, 12(1), Article 224. https://doi.org/10.1186/s12974-015-0445-y

Brooks, D. J. (2015). The Anatomy of Parkinsonian Disorders. In Social Cognitive Neuroscience, Cognitive Neuroscience, Clinical Brain Mapping (Vol. 3, pp. 759-767). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-397025-1.00087-7

Senda, M., Brooks, D. J., Farrar, G., Somer, E. J., Paterson, C. L., Sasaki, M. & McParland, B. J. (2015). The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (F-18) injection in healthy Japanese adult volunteers. Annals of nuclear medicine, 29(7), 627-635. https://doi.org/10.1007/s12149-015-0986-2

Pasqualetti, G., Brooks, D. J. & Edison, P. (2015). The Role of Neuroinflammation in Dementias. Current Neurology and Neuroscience Reports, 15(4), Article 17. https://doi.org/10.1007/s11910-015-0531-7

Smith, R., Wu, K., Hart, T., Loane, C., Brooks, D. J., Bjorklund, A., Odin, P., Piccini, P. & Politis, M. (2015). The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study. Neurobiology of Aging, 36(4), 1736-1742. https://doi.org/10.1016/j.neurobiolaging.2014.12.037

Hyder, F., Herman, P., Bailey, C. J., Møller, A., Globinsky, R., Fulbright, R. K., Rothman, D. L. & Gjedde, A. (2015). Uniform distributions of glucose oxidation and oxygen extraction in gray matter of normal human brain: No evidence of regional differences of aerobic glycolysis. Journal of Cerebral Blood Flow and Metabolism, 36(5), 903-916. https://doi.org/10.1177/0271678X15625349

Lillethorup, T. P., Iversen, P., Wegener, G., Doudet, D. J. M. & Landau, A. M. (2015). α2-adrenoceptor binding in Flinders-sensitive line compared with Flinders-resistant line and Sprague-Dawley rats. Acta Neuropsychiatrica (Print), 1-8. https://doi.org/10.1017/neu.2015.24

Palmqvist, S., Zetterberg, H., Blennow, K., Vestberg, S., Andreasson, U., Brooks, D. J., Owenius, R., Hägerström, D., Wollmer, P., Minthon, L. & Hansson, O. (2014). Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurology, 71(10), 1282-9. https://doi.org/10.1001/jamaneurol.2014.1358

Rømer Thomsen, K., Fjorback, L., Møller, A. & Lou, H. C. (2014). Applying incentive sensitization models to behavioral addiction. Neuroscience & Biobehavioral Reviews, 45(2014), 343. https://doi.org/10.1016/j.neubiorev.2014.07.009

Grecchi, E., Doyle, O. M., Bertoldo, A., Pavese, N. & Turkheimer, F. E. (2014). Brain shaving: Adaptive detection for brain PET data. Physics in Medicine and Biology, 59(10), 2517-2534. https://doi.org/10.1088/0031-9155/59/10/2517

Yarnall, A. J., Breen, D. P., Duncan, G. W., Khoo, T. K., Coleman, S. Y., Firbank, M. J., Nombela, C., Winder-Rhodes, S., Evans, J. R., Rowe, J. B., Mollenhauer, B., Kruse, N., Hudson, G., Chinnery, P. F., O'Brien, J. T., Robbins, T. W., Wesnes, K., Brooks, D. J., Barker, R. A. ... ICICLE-PD Study Group (2014). Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study. Neurology, 82(4), 308-16. https://doi.org/10.1212/WNL.0000000000000066

Borghammer, P., Knudsen, K., Østergaard, K., Danielsen, E. H., Pavese, N., Arveschoug, A., Bluhme, H., Bode, M. & Morsing, A. (2014). Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders. International Journal of Clinical Practice, 68(11), 1345-51. https://doi.org/10.1111/ijcp.12445

van Hartevelt, T. J., Cabral, J., Møller, A., Fitzgerald, J. J., Green, A. L., Aziz, T. Z., Deco, G. & Kringelbach, M. L. (2014). First evidence of neural mechanisms of Hebbian changes in white matter tracts induced by long-term deep brain stimulation. Poster session presented at Society for Neuroscience 2014, Washington DC, United States.

Nombela, C., Rowe, J. B., Winder-Rhodes, S. E., Hampshire, A., Owen, A. M., Breen, D. P., Duncan, G. W., Khoo, T. K., Yarnall, A. J., Firbank, M. J., Chinnery, P. F., Robbins, T. W., O'Brien, J. T., Brooks, D. J., Burn, D. J., Barker, R. A. & ICICLE-PD Study Group (2014). Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain, 137(Pt 10), 2743-58. https://doi.org/10.1093/brain/awu201

Duncan, G. W., Khoo, T. K., Yarnall, A. J., O'Brien, J. T., Coleman, S. Y., Brooks, D. J., Barker, R. A. & Burn, D. J. (2014). Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Movement Disorders, 29(2), 195-202. https://doi.org/10.1002/mds.25664

Pavese, N. (2014). Imaging the Aetiology of Sleep Disorders in Dementia and Parkinson’s Disease. Current Neurology and Neuroscience Reports, 14(501). https://doi.org/10.1007/s11910-014-0501-5

Callesen, M. B., Weintraub, D., Damholdt, M. F. & Møller, A. (2014). Impulsive and compulsive behaviors among Danish patients with Parkinson’s diseass: Prevalence, depression, and personality. Parkinsonism & Related Disorders, 20(1), 22-26. https://doi.org/10.1016/j.parkreldis.2013.09.006

Garvey, L. J., Pavese, N., Politis, M., Ramlackhansingh, A., Brooks, D. J., Taylor-Robinson, S. D. & Winston, A. (2014). Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS, 28(1), 67-72. https://doi.org/10.1097/01.aids.0000432467.54003.f7

Fan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K., Brooks, D. J. & Edison, P. (2014). Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2014.06.016

McGinnity, C. J., Hammers, A., Riaño Barros, D. A., Luthra, S. K., Jones, P. A., Trigg, W., Micallef, C., Symms, M. R., Brooks, D. J., Koepp, M. J. & Duncan, J. S. (2014). Initial Evaluation of 18F-GE-179, A Putative PET Tracer for Activated N-Methyl D-Aspartate Receptors. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.113.130641

Watson, B. J., Taylor, L. G., Reid, A. G., Wilson, S. J., Stokes, P. R., Brooks, D. J., Myers, J. F., Turkheimer, F. E., Nutt, D. J. & Lingford-Hughes, A. R. (2014). Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET. Addiction Biology (Online), 19(6), 1032-40. https://doi.org/10.1111/adb.12073

Gjerløff, T., Jakobsen, S., Nahimi, A., Munk, O. L., Bender, D., Alstrup, A. K. O., Vase, K. H., Brooks, D. J. & Borghammer, P. (2014). In Vivo Imaging of Human Acetylcholinesterase Density in Peripheral Organs Using 11C-Donepezil: Dosimetry, Biodistribution, and Kinetic Analyses. Journal of Nuclear Medicine, 55(11), 1818-24. https://doi.org/10.2967/jnumed.114.143859

Sabers, A., Bertelsen, F. C. B., Scheel-Krüger, J., Nyengaard, J. R. & Møller, A. (2014). Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism. Neuroscience Letters, 580, 12-6. https://doi.org/10.1016/j.neulet.2014.07.036

Van Hartevelt, T. J., Cabral, J., Deco, G., Møller, A., Green, A. L., Aziz, T. Z. & Kringelbach, M. L. (2014). Neural plasticity in human brain connectivity: The effects of long term deep brain stimulation of the subthalamic nucleus in Parkinson's disease. P L o S One, 9(1), Article e86496. https://doi.org/10.1371/journal.pone.0086496

Doudet, D. J., Clark, C., Alstrup, A. K. O., Jakobsen, S., Gjedde, A., Wegener, G., Videbech, P. & Landau, A. M. (2014). Of Pig and Man: Analogy of response to electroconvulsive therapy (ECT): most do, a few don’t. Abstract from CINP World Congress, Vancouver, Canada.

Damholdt, M. F., Callesen, M. B. & Møller, A. (2014). Personality characteristics of depressed and non-depressed patients with Parkinson's Disease. Journal of Neuropsychiatry and Clinical Neurosciences, 26(4), 329-334. https://doi.org/10.1176/appi.neuropsych.13040085

Winterdahl, M., Audrain, H., Landau, A. M., Smith, D. F., Bonaventure, P., Shoblock, J. R., Carruthers, N., Swanson, D. & Bender, D. (2014). PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs. Journal of Nuclear Medicine, 55(4), 635-9. https://doi.org/10.2967/jnumed.113.125351

Brooks, D. J. (2014). PET imaging in neuroinflammation. In Inflammation in Parkinson's Disease: Scientific and Clinical Aspects (pp. 205-216). Springer International Publishing. https://doi.org/10.1007/978-3-319-08046-8_9

Brooks, D. J. (2014). PET imaging of translocator protein expression in neurological disorders. In PET and SPECT of Neurobiological Systems (pp. 653-667). Springer. https://doi.org/10.1007/978-3-642-42014-6_22

Wilkinson, L., Tai, Y. F., Lin, C. S., Lagnado, D. A., Brooks, D. J., Piccini, P. & Jahanshahi, M. (2014). Probabilistic classification learning with corrective feedback is associated with in vivo striatal dopamine release in the ventral striatum, while learning without feedback is not. Human Brain Mapping, 35(10), 5106-15. https://doi.org/10.1002/hbm.22536

Yousif, N., Pavese, N., Naushahi, M. J., Nandi, D. & Bain, P. G. (2014). Reversing the polarity of bipolar stimulation in deep brain stimulation for essential tremor: a theoretical explanation for a useful clinical intervention. Neurocase, 20(1), 10-7. https://doi.org/10.1080/13554794.2012.713495

Politis, M., Wu, K., Loane, C., Brooks, D. J., Kiferle, L., Turkheimer, F. E., Bain, P., Molloy, S. & Piccini, P. (2014). Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. Journal of Clinical Investigation. https://doi.org/10.1172/JCI71640

Simonsen, A., Scheel-Krüger, J., Jensen, M., Roepstorff, A., Møller, A., Frith, C. D. & Campbell-Meiklejohn, D. (2014). Serotoninergic effects on judgments and social learning of trustworthiness. Psychopharmacology. https://doi.org/10.1007/s00213-014-3444-2

Riaño Barros, D. A., McGinnity, C. J., Rosso, L., Heckemann, R. A., Howes, O. D., Brooks, D. J., Duncan, J. S., Turkheimer, F. E., Koepp, M. J. & Hammers, A. (2014). Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP. NeuroImage, 97, 151-62. https://doi.org/10.1016/j.neuroimage.2014.04.020

Lawrence, A. D. & Brooks, D. J. (2014). Ventral striatal dopamine synthesis capacity is associated with individual differences in behavioral disinhibition. Frontiers in Behavioral Neuroscience, 8, 86. https://doi.org/10.3389/fnbeh.2014.00086

Mollenhauer, B., Rochester, L., Chen-Plotkin, A. & Brooks, D. (2014). What can biomarkers tell us about cognition in Parkinson's disease? Movement Disorders, 29(5), 622-33. https://doi.org/10.1002/mds.25846

Nordberg, A., Carter, S. F., Rinne, J., Drzezga, A., Brooks, D. J., Vandenberghe, R., Perani, D., Forsberg, A., Långström, B., Scheinin, N., Karrasch, M., Någren, K., Grimmer, T., Miederer, I., Edison, P., Okello, A., Van Laere, K., Nelissen, N., Vandenbulcke, M. ... Herholz, K. (2013). A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging, 40(1), 104-14. https://doi.org/10.1007/s00259-012-2237-2

Rømer Thomsen, K., Joensson, M., Lou, H. O. C., Møller, A., Gross, J., Kringelbach, M. L. & Changeux, J.-P. (2013). Altered paralimbic interaction in behavioral addiction. Proceedings of the National Academy of Sciences (PNAS), 110(12), 4744-9. https://doi.org/10.1073/pnas.1302374110

Doudet, D., Jakobsen, S., Alstrup, A. K. O., Møller, A., Sørensen, J. C. H. & Landau, A. M. (2013). A model of Parkinson’s Disease in pig and primate by repeated intraventricular administration of an inhibitor of the ubiquitin proteasome system (UPS). Abstract from XX World Congress on Parkinson´s Disease and related disorders, Geneva, Switzerland.

Doudet, D., Jakobsen, S., Alstrup, A. K. O., Møller, A., Sørensen, J. C. H. & Landau, A. M. (2013). A model of Parkinson’s disease (PD) in pig and primate by repeated ICV administration of an inhibitor of the ubiquitin proteasome system (UPS). Poster session presented at XX World Congress on Parkinson´s Disease and related disorders, Geneva, Switzerland.

Bertelsen, F. C. B., Møller, A., Landau, A. M. & Scheel-Krüger, J. (2013). AN ANIMAL MODEL FOR THE FETAL VALPROATE SYNDROME: – WITH RELEVANCE TO AUTISM. Poster session presented at The International Meeting for Autism Research (IMFAR) , San Sebastian, Spain.

Aamand, R., Dalsgaard, T., Ho, Y. C. L., Møller, A., Roepstorff, A. & Lund, T. E. (2013). A NO way to BOLD? Dietary nitrate alters the hemodynamic response to visual stimulation. NeuroImage, 83C, 397-407. https://doi.org/10.1016/j.neuroimage.2013.06.069

Ray Chaudhuri, K., Rojo, J. M., Schapira, A. H. V., Brooks, D. J., Stocchi, F., Odin, P., Antonini, A., Brown, R. J. & Martinez-Martin, P. (2013). A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need. PLOS ONE, 8(2), e57221. https://doi.org/10.1371/journal.pone.0057221

Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L. & Møller, A. (2013). A Systematic Review of Impulse Control Disorders in Parkinson's Disease. Journal of Parkinson's Disease, 3(2), 105-138. https://doi.org/10.3233/JPD-120165

Cenci, M. A. & Brooks, D. (2013). Bad news for neuroprotective therapies in PD? Journal of Parkinson's Disease, 3(3), 271-3. https://doi.org/10.3233/JPD-139001

Patel, N. K., Pavese, N., Javed, S., Hotton, G. R., Brooks, D. J. & Gill, S. S. (2013). Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation. Neurology, 81(13), 1176-8. https://doi.org/10.1212/WNL.0b013e3182a55ea5

Vandenberghe, R., Nelissen, N., Salmon, E., Ivanoiu, A., Hasselbalch, S., Andersen, A., Korner, A., Minthon, L., Brooks, D. J., Van Laere, K. & Dupont, P. (2013). Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI. NeuroImage, 64, 517-25. https://doi.org/10.1016/j.neuroimage.2012.09.015

Keiding, S. & Pavese, N. (2013). Brain metabolism in patients with hepatic encephalopathy studied by PET and MR. Archives of Biochemistry and Biophysics, 536(2), 131-42. https://doi.org/10.1016/j.abb.2013.05.006

Landau, A. M., Alstrup, A. K. O., Wegener, G., Jakobsen, S., Schacht, A. C., Jacobsen, J., Mørk, A., Sørensen, J. C. H. & Doudet, D. (2013). Combined PET/microdialysis studies in minipig for PET tracer validation. Abstract from Minipig Research Forum, Rom, Italy.

Edison, P., Carter, S. F., Rinne, J. O., Gelosa, G., Herholz, K., Nordberg, A., Brooks, D. J. & Hinz, R. (2013). Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. NeuroImage, 70, 423-33. https://doi.org/10.1016/j.neuroimage.2012.12.014

Phan, J.-A., Landau, A. M., Jakobsen, S., Doudet, D. & Gjedde, A. (2013). Differential Amphetamine and Ligand Concentration Inhibition of 11C-Yohimbine binding in Brain: Effect of Plasma Protein Binding Displacement..

Displaying results 201 to 400 out of 1061

Revised 01.06.2022

Henriette Blæsild Vuust